Piperine may lead to the downregulation of soluble E-cadherin fragments by inhibiting cleavage of E-cadherin protein, inhibiting cell movement and activation of β-catenin, and thus, inhibiting the development of malignant tumors. This evidence concerns the gene CDH1 and cancer.